This protocol is judged by an institutional overview board, an impartial group that reviews any clinical trials involving individuals. If a analyze involves a Routine I drug, once the board approves the protocol as ethical, the scientists need to apply for an investigational new drug (IND) amount through the FDA.When beneath the impact of this drug